Introduction

Bell’s palsy (BP) is mostly idiopathic, but viral infections as herpes simplex virus, varicella-zoster virus, and Epstein-Barr virus are suggested [1].The incidence is 15 to 20 per 100,000. The recurrence rate is about 10% [2].The pathophysiology of Bell’s palsy includes compression of facial nerve at the internal auditory meatus, due to the inflammatory edema leading to temporary loss of sensory or motor function, but it could lead to permanent nerve degeneration later [3].

There are several studies suggesting the association between diabetes, hypertension, and hypercholesterolemia with poor prognosis of Bell’s palsy; however, other studies did not find this association [4,5,6]. The advanced grade of BP at the time of presentation is associated with poor prognosis [7].

The House and Brackmann (HB) grading system is the most widely accepted system for measurement of the facial nerve functions [8]. The American Academy of Otolaryngology-Head and Neck Surgery adopted this scale as a universal standard for grading facial nerve recovery [9].

The prognosis of Bell’s palsy has been predicted based mainly on various electrophysiologic tests especially electroneurography “ENoG” [10]. ENoG can determine the percentage of degenerating nerve fibers in early phase of acute facial paralysis. Various studies [11,12,13] have shown that ENoG can be used to predict the prognosis of acute facial paralysis.

The present study was designed to verify which clinical or electrophysiological parameters could be considered as predictive of the degree of recovery of patients with Bell’s palsy.

Subjects and methods

Subjects

This observational study was carried out during the period from November 2017 to September 2018 in Neurology Department, Mansoura University Hospital. The study included 63 patients with Bell’s palsy.

Inclusion criteria

Inclusion criteria were adults aged between 18 and 70 years with unilateral BP and standardized oral pharmacological treatment within 48 h.

Exclusion criteria

Exclusion criteria were any sign of infective, central, and peripheral nervous system disease or temporal bone pathologies.

Methods

Clinical evaluation

Informed consent

All patients signed a written consent before included in the study. History taking and complete neurological examination were done at the outpatient clinic of the department of neurology at Mansoura University Hospital.

Diagnosis of diabetes, hypertension, and dyslipidemia

Diabetes, hypertension, and dyslipidemia were defined according to the guidelines from the National Heart, Lung, and Blood Institute and the American Heart Association [14]:

  1. 1-

    Diabetes: Fasting blood glucose level was ≥ 100 mg/dl or using insulin or oral hypoglycemic agents.

  2. 2-

    Hypertension: Elevated blood pressure (systolic blood pressure ≥ 130 mmHg and/or diastolic blood pressure ≥ 85 mmHg or current use of antihypertensive drugs).

  3. 3-

    Dyslipidemia: Hypertriglyceridemia (triglycerides ≥ 150 mg/dl) and/or use of cholesterol lowering medications; low HDL cholesterol (HDL cholesterol < 40 mg/dl for men and < 50 mg/dl for women).

House and Brackmann (HB) facial scoring system

Bell’s palsy in all patients was initially assessed according to the House and Brackmann facial scoring system “HB system”. It is a 6-point scale intended for categorizing overall facial nerve function from normal to complete paralysis (grades 1–6) [8]. All patients were followed for 3 months; the functional recovery then reassessed according to HB system and divided into: grades 1 and 2: complete recovery, grade 3: incomplete recovery, grades 4 and 5: poor recovery [15].

Electrophysiology

Nerve conduction studies were measured on the affected side using neuropack 2 Nihon Kohden Japan, model MEB/MEM. 7102A/K02 surface electrode recording was done using surface electrodes placed over the frontalis, nasalis, and orbicularis oculi muscles, increasing current intensity to evoke compound muscle action potential. Distal latency and amplitude of the response were determined [16].

Statistical analysis

The collected data were coded, processed, and analyzed using the SPSS (Statistical Package for Social Sciences) version 15 Windows (SPSS Inc, Chicago, IL, USA). Qualitative data were presented as number and percent. Comparison between groups was done by Chi-Square test. Quantitative data was presented as mean ± SD. Student t test was used to compare between two groups. Non parametric data was presented as min–max and median. Mann–Whitney test was used for comparison between groups. p < 0.05 was considered to be statistically significant.

Results

The House–Brackmann (HB) grading system at the onset and after 3 months was used for the clinical evaluation of Bell’s palsy. We classified our patients into 2 groups; group 1 (good prognosis) with HB grade 1 or 2 in the third month of clinical follow-up and group 2 (poor prognosis) with grade 3 or higher.

The demographic and clinical characteristics of the 63 studied patients are summarized in Table 1. There were no statistically significant differences between the 2 groups as regards age at onset and sex (p = 0.946 and p = 0.441 respectively). There were 52 patients with good prognosis (group 1) and 11 patients with poor prognosis (group 2)

Table 1 Demography and clinical characteristics
Full size table

Thirty-five patients (67.3%) in group 1 and 8 patients (72.7%) presented within 3 days of onset with no statistically significant differences between the 2 groups (p = 0.726). Seventeen patients in group 1 and 3 patients in group 2 presented within the first 10 days of onset. There were no statistically significant differences between group 1 and 2 as regards diabetes, hypertension, and dyslipidemia (p = 0.207, p = 0.622, and p = 0.941 (respectively)) (Table 1).

Initial HB was 5.17 ± 0.90 in group 1 and 5.55 ± 0.52 in group 2 with no statistically significant differences between the 2 groups (p = 0.192) while HB after 3 months was 1.44 ± 0.50 in group 1 and 3.18 ± 0.40 in group 2 with statistically significant differences between both groups (p < 0.001) (Table 1).

Neurophysiological characteristics are shown in Table 2. The mean CMAP latency of frontalis muscle was 3.79 ± 0.79 ms in group 1 and 4.04 ± 0.92 ms in group 2 with no statistically significant differences between both groups (p = 0.308). The mean CMAP amplitude of frontalis muscle was 1.06 ± 0.69 in group 1 and 0.31 ± 0.17 in group 2 with statistically significant differences between both groups (p < 0.001) (Table 2).

Table 2 Neurophysiological characteristics
Full size table

The mean CMAP latency of nasalis muscle was 3.68 ± 0.62 ms in group 1 and 3.95 ± 0.8 ms in group 2 with no statistically significant differences between both groups (p = 0.178). The mean CMAP amplitude of nasalis muscle was 1.40 ± 0.7 in group 1 and 0.85 ± 0.21 in group 2 with statistically significant differences between both groups (p = 0.001) (Table 2).

The mean CMAP latency of orbicularis oris muscle was 3.91 ± 0.50 ms in group 1 and 4.23 ± 0.83 ms in group 2 with no statistically significant differences between both groups (p = 0.101). The mean CMAP amplitude of orbicularis muscle was 1.27 ± 0.59 in group 1 and 0.80 ± 0.25 in group 2 with statistically significant differences between both groups (p = 0.001) (Table 2).

Discussion

There is a great difference in the response of patients with Bell’s palsy to treatment and it would be beneficial if we have a tool to predict its outcome since facial nerve is very important for facial expression [17, 18]. There are many studies for early prediction of outcome of Bell’s palsy but these studies are difficult to compare due to variation in design and selection criteria [19, 20].

In our study, we could not find statistically significant differences between patients with Bell’s palsy with good prognosis and poor prognosis as regards age (p = 0 .946) and sex (p = 0.411). These findings are in agreement with previous studies which found no significant relationship between Bell’s palsy prognosis, age, and sex [21,22,23], although Ikeda et al. found that age and gender may affect the progression of Bell’s palsy [24].

In our work, there were no statistically significant differences between the 2 groups as regards the start of treatment after the onset of BP (p = 0.726). There are few studies for the relationship between the time of treatment of Bell’s palsy and its prognosis. In contrast to our findings, Yeo et al. found that treatment within 3 days has been associated with better outcome than later treatment [25]. Treatment within first day of onset has been found to have good outcome in a study of patients with severe Bell’s palsy [26].

In our study, there were no statistically significant differences between group1 (good prognosis) and group 2 (poor prognosis) as regards diabetes, hypertension, or dyslipidemia (p > 0.05). In accordance to our findings, some authors found that diabetes in patients with Bell’ palsy is not higher than in the general population [27,28,29]. For example, Kudoh et al. reported that Bell’s palsy scores are not affected by diabetes or hypertension, although patients with both diabetes and hypertension had poorer recovery [30]. In contrast to our findings, recovery from Bell’s palsy in diabetic patients was found to be poor compared to non-diabetic patients and the maximum treatments might be beneficial in these patients [4].

In another study, the recovery rate of Bell’s palsy was correlated with diabetes and high triglycerides [31]. Fujiwara et al. reported no correlation between diabetes mellitus and non-recovery from Bell’s palsy [32]. Abraham et al. have found the presence of hypertension as a poor prognostic indicator for patients with Bell’s palsy [7].

In our study, there were no statistically significant differences between the 2 groups as regards the initial total HB score (p = 0.192) while total HB score after 3 months was statistically significant between both groups (p < 0.001). In contrast to our findings, Coulson et al. found that the initial HB grading on a single clinical examination could be used to determine the prognosis of Bell’s palsy [33].

Our work showed less decrease in the amplitude of frontalis, nasalis, and orbicularis oris muscles in group 1 (good prognosis) than group 2 (poor prognosis) with statistically significant difference (p = < 0.001 for frontalis, p = 0.001 for nasalis, p = 0.001 for orbicularis oris). The terminal latency showed no significant differences between the two groups (p = 0.308 for frontalis, p = 0.178 for nasalis, p = 0.101 for orbicularis oris). Several studies have found a special prognostic value of the amplitude of the compound muscle action potential (CMAP) in Bell’s palsy. For example, May et al. showed that amplitude reductions less than 10% were highly associated with poor recovery [34]. Gantz et al. showed that patients who reached 90% degeneration on ENoG within 2 weeks of onset returned to HB grade 1 or 2 within 7 months [35]. Fisch reported good recovery in half of patients with 90% or more ENoG degeneration and 80% recovery in patients with less than 90% degeneration [11]. The diagnostic and prognostic value of the CMAP latency was discussed in other studies, since the CMAP latency determines the viability of the fast axons, so it can remain within a normal range for a long time [21].

Conclusions

The initial electroneurography (ENoG) is more predictive of recovery of Bell’s palsy than the initial clinical grading using the House–Brackmann (HB) grading system. Age, sex, hypertension, diabetes, and dyslipidemia do not seem to correlate with the degree of recovery in Bell’s palsy.